Sprint Bioscience Ab Stock Shares Outstanding
SPRINT Stock | SEK 1.33 0.02 1.53% |
Sprint Bioscience AB fundamentals help investors to digest information that contributes to Sprint Bioscience's financial success or failures. It also enables traders to predict the movement of Sprint Stock. The fundamental analysis module provides a way to measure Sprint Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sprint Bioscience stock.
Sprint |
Sprint Bioscience AB Company Shares Outstanding Analysis
Sprint Bioscience's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Sprint Bioscience Shares Outstanding | 69.8 M |
Most of Sprint Bioscience's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sprint Bioscience AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition |
Based on the latest financial disclosure, Sprint Bioscience AB has 69.8 M of shares currently outstending. This is 61.34% lower than that of the Healthcare sector and 82.62% lower than that of the Drug Manufacturers - Specialty & Generic industry. The shares outstanding for all Sweden stocks is 87.79% higher than that of the company.
Sprint Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sprint Bioscience's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sprint Bioscience could also be used in its relative valuation, which is a method of valuing Sprint Bioscience by comparing valuation metrics of similar companies.Sprint Bioscience is currently under evaluation in shares outstanding category among related companies.
Sprint Fundamentals
Return On Equity | -1.09 | |||
Return On Asset | -0.59 | |||
Operating Margin | (76.00) % | |||
Current Valuation | 24.98 M | |||
Shares Outstanding | 69.8 M | |||
Shares Owned By Insiders | 35.31 % | |||
Shares Owned By Institutions | 2.59 % | |||
Price To Earning | 32.79 X | |||
Price To Book | 2.61 X | |||
Price To Sales | 27.09 X | |||
Revenue | 35.11 M | |||
Gross Profit | 24.59 M | |||
EBITDA | (24.22 M) | |||
Net Income | (25.08 M) | |||
Cash And Equivalents | 13.82 M | |||
Cash Per Share | 1.19 X | |||
Debt To Equity | 32.20 % | |||
Current Ratio | 2.69 X | |||
Book Value Per Share | 0.63 X | |||
Cash Flow From Operations | (40.12 M) | |||
Earnings Per Share | (0.75) X | |||
Target Price | 32.0 | |||
Number Of Employees | 34 | |||
Beta | 1.32 | |||
Market Capitalization | 53.17 M | |||
Total Asset | 79.14 M | |||
Retained Earnings | (39 M) | |||
Working Capital | 4 M | |||
Current Asset | 25 M | |||
Current Liabilities | 21 M | |||
Net Asset | 79.14 M |
About Sprint Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sprint Bioscience AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sprint Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sprint Bioscience AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sprint Bioscience AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Sprint Stock analysis
When running Sprint Bioscience's price analysis, check to measure Sprint Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sprint Bioscience is operating at the current time. Most of Sprint Bioscience's value examination focuses on studying past and present price action to predict the probability of Sprint Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sprint Bioscience's price. Additionally, you may evaluate how the addition of Sprint Bioscience to your portfolios can decrease your overall portfolio volatility.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |